A special plant-based formulation of rosmarinic acid significantly lowered blood pressure and blood sugar levels in laboratory animals with both conditions, outperforming regular rosmarinic acid and matching standard medications. According to Gram Research analysis, the phytosomal delivery system improved the plant compound’s effectiveness, and treated animals showed near-normal tissue structure in vital organs like the heart and kidneys. However, human studies are needed before this can be recommended as a treatment.
Researchers tested a special form of rosmarinic acid—a compound from rosemary plants—to see if it could help treat two conditions that often happen together: diabetes and high blood pressure. According to Gram Research analysis, the plant extract in a new formulation called a phytosome worked better than the regular plant extract and performed similarly to standard medications. The treatment improved blood sugar control, lowered blood pressure, and protected organs like the heart and kidneys from damage. While these results are promising, the study was done in animals, so more research in humans is needed before doctors can recommend it.
Key Statistics
A 2026 animal study found that rosmarinic acid phytosome significantly reduced blood pressure and blood glucose levels while improving lipid metabolism and decreasing kidney stress markers compared to untreated controls.
Research published in 2026 demonstrated that the phytosomal formulation of rosmarinic acid showed greater efficacy than conventional rosmarinic acid, likely due to improved bioavailability and absorption in the body.
A 2026 study revealed that rosmarinic acid phytosome treatment resulted in near-normal tissue architecture in the heart, kidneys, and pancreas, suggesting protection against organ damage from both diabetes and high blood pressure.
The Quick Take
- What they studied: Whether a new plant-based formulation of rosmarinic acid (a compound from rosemary) could help treat both high blood pressure and diabetes at the same time
- Who participated: Laboratory rats that were given either high-fructose diets or special injections to create conditions similar to human diabetes and high blood pressure
- Key finding: The rosmarinic acid phytosome significantly lowered blood pressure and blood sugar levels, improved cholesterol profiles, and protected organs from damage better than regular rosmarinic acid
- What it means for you: This research suggests a plant-based option might one day help people manage two serious conditions together, but human studies are needed first. Don’t replace your current medications without talking to your doctor.
The Research Details
Scientists created two disease models in rats: one group developed high blood pressure from eating a high-fructose diet (similar to how processed foods affect humans), and another group developed diabetes through a chemical injection. The researchers then divided the sick animals into groups: some received the new rosmarinic acid phytosome formulation, some received regular rosmarinic acid, some received standard medications (captopril for blood pressure and acarbose for diabetes), and some received no treatment as a control group.
A phytosome is a special delivery system that wraps plant compounds in a protective coating, similar to putting medicine in a capsule. This coating helps the body absorb the plant compound better. The researchers measured multiple health markers including blood pressure, blood sugar levels, cholesterol, kidney function, and how well the body’s natural defense system (antioxidants) was working.
After treatment, the scientists examined tissue samples from the heart, kidneys, and pancreas under a microscope to see if the organs had been damaged or if they looked healthier.
This research approach is important because it tests whether a plant compound can address multiple disease pathways at once. Many people with diabetes also have high blood pressure, and treating both conditions together is challenging. By using a special delivery system (phytosome), researchers could test whether better absorption of the plant compound makes it more effective than the regular form.
This is an animal study, which is an important early step in drug development but doesn’t directly prove the treatment works in humans. The study measured many different health markers, which strengthens the findings. However, the abstract doesn’t specify the exact number of animals used or provide detailed statistical analysis. Animal studies typically have good internal validity but lower real-world applicability. Further human clinical trials would be needed to confirm these results.
What the Results Show
The rosmarinic acid phytosome treatment produced significant improvements in both blood pressure and blood sugar control. Animals treated with the phytosome formulation showed blood pressure reductions and blood glucose improvements comparable to or better than animals receiving standard medications like captopril and acarbose.
Beyond these main effects, the treatment improved the animals’ lipid profiles (cholesterol and fat levels in the blood), which is important because high cholesterol often accompanies diabetes and high blood pressure. The phytosomal formulation also reduced markers of kidney stress, suggesting protection of this vital organ that’s often damaged by both conditions.
The treated animals showed enhanced antioxidant activity, meaning their bodies’ natural defense systems against cellular damage were strengthened. This is significant because oxidative stress (cellular damage from harmful molecules) plays a major role in both diabetes and high blood pressure complications.
When researchers examined tissue samples under the microscope, organs from treated animals showed near-normal architecture, meaning the heart, kidneys, and pancreas looked much healthier than in untreated animals. In contrast, untreated animals showed significant tissue damage and abnormal structures in these organs.
The phytosomal formulation of rosmarinic acid outperformed the regular rosmarinic acid extract, likely because the special delivery system improved how much of the compound the body could actually use. This suggests that how a plant compound is delivered matters as much as the compound itself. The study also showed that the plant-based approach produced benefits across multiple organ systems simultaneously, rather than just affecting one area.
This research builds on earlier studies showing that rosmarinic acid has antioxidant and anti-inflammatory properties. However, this appears to be one of the first studies testing whether a phytosomal formulation of rosmarinic acid could treat both diabetes and high blood pressure together in a single treatment. Previous research typically focused on one condition at a time. The finding that the phytosomal delivery system improved effectiveness compared to regular rosmarinic acid aligns with broader research showing that how we deliver plant compounds affects their usefulness.
This study was conducted entirely in animals, so results may not directly translate to humans. The abstract doesn’t specify the exact number of animals used or provide detailed statistical comparisons between groups. The study used artificially induced disease models, which may not perfectly replicate how these conditions develop and progress in humans. The research doesn’t address long-term safety or whether benefits would persist with continued use. Additionally, there’s no information about optimal dosing for humans or potential side effects in people. More research is needed before this could be recommended as a treatment.
The Bottom Line
Based on this animal research, rosmarinic acid phytosome shows promise as a potential future treatment for people with both diabetes and high blood pressure. However, confidence in these recommendations is currently low because human studies haven’t been conducted yet. Do not stop taking prescribed medications or replace them with rosmarinic acid products based on this research. If you’re interested in plant-based supplements, discuss options with your healthcare provider.
People with both diabetes and high blood pressure should be aware of this emerging research, as it addresses their specific situation. Healthcare providers researching new treatment options should note these findings. However, this research is not yet ready for general public use. People with only one of these conditions may find this less immediately relevant. Pregnant women, people with kidney disease, and those taking blood-thinning medications should wait for more safety data.
In this animal study, benefits appeared within the treatment period, but the exact duration wasn’t specified in the abstract. If this advances to human trials, it typically takes 5-10 years of research before a new plant-based treatment becomes available to the general public. Don’t expect immediate access to this as a treatment option.
Frequently Asked Questions
Can I take rosmarinic acid supplements to treat my diabetes and high blood pressure?
Not yet based on this research. This study was conducted in animals only. While results are promising, human clinical trials are needed before rosmarinic acid phytosomes can be recommended as a treatment. Continue taking medications prescribed by your doctor.
How does the phytosomal formulation work differently than regular rosmarinic acid?
The phytosomal formulation uses a special delivery system that wraps the plant compound in a protective coating, similar to a capsule. This coating helps your body absorb and use more of the rosmarinic acid, making it more effective than the regular form.
When will rosmarinic acid phytosome be available as a treatment for patients?
This research is still in early stages. Human clinical trials would need to be conducted first, which typically takes several years. If successful, regulatory approval would follow. It could be 5-10 years before this becomes available as a medical treatment.
Why is treating diabetes and high blood pressure together important?
These two conditions often occur together and damage the same organs, particularly the heart and kidneys. A single treatment targeting both conditions simultaneously could be more effective and simpler for patients than taking multiple separate medications.
Are there any risks or side effects mentioned in this study?
The study focused on effectiveness in animals and didn’t report safety concerns, but it also didn’t thoroughly investigate potential side effects. More research in humans is needed to identify any risks before this can be recommended as a treatment.
Want to Apply This Research?
- Track daily blood pressure readings and fasting blood glucose levels at the same time each morning. Record these measurements in a health app to identify patterns and share with your doctor during appointments.
- While waiting for potential future treatments, use the app to monitor how diet changes (reducing processed foods and added sugars) affect your blood pressure and blood sugar. Set reminders to take current medications as prescribed and log any side effects.
- Create a long-term dashboard showing blood pressure and glucose trends over weeks and months. Set monthly check-in reminders to review your data with your healthcare provider and adjust lifestyle factors accordingly. When this treatment becomes available for human testing, this baseline data will be valuable for comparison.
This research was conducted in laboratory animals and has not been tested in humans. These findings do not constitute medical advice or approval for human use. Do not discontinue, replace, or modify any diabetes or blood pressure medications based on this research without consulting your healthcare provider. Rosmarinic acid phytosomes are not currently approved by the FDA as a medical treatment. If you have diabetes, high blood pressure, or both conditions, work with your doctor to develop an appropriate treatment plan. This article is for informational purposes only and should not be used for self-diagnosis or self-treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.